What are the recommended medications for motion sickness in children?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 30, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Medications for Motion Sickness in Children

For children with motion sickness, dimenhydrinate and diphenhydramine are the recommended first-line medications for those over 6 years of age, while children under 6 years should generally avoid antihistamine medications due to safety concerns. 1, 2

First-Line Medication Options

  • Dimenhydrinate is FDA-approved for prevention and treatment of nausea, vomiting, and vertigo associated with motion sickness in children over 6 years of age 1
  • For children 6-12 years: diphenhydramine 10 mL (25 mg) every 4-6 hours, not exceeding 6 doses in 24 hours 2
  • For children over 12 years: diphenhydramine 10-20 mL (25-50 mg) every 4-6 hours, not exceeding 6 doses in 24 hours 2
  • Dimenhydrinate dosing for children: 1.25 mg/kg of body weight or 37.5 mg/m² of body surface area administered four times daily, not exceeding 300 mg daily 1

Important Safety Considerations

  • Children under 6 years of age should not use over-the-counter antihistamines for motion sickness due to potential toxicity and safety concerns 3
  • FDA advisory committees have recommended against using OTC cough and cold medications (including antihistamines) in children under 6 years due to safety concerns and reported fatalities 3
  • Between 1969 and 2006, there were 69 fatalities associated with three antihistamines in children under 6 years, with 41 reported in children under 2 years 3

Alternative Options for Children

  • For children who cannot take antihistamines, non-pharmacological approaches should be considered first 4
  • Ginger has antinausea properties that act directly on the stomach rather than the central nervous system, making it potentially safer for children 4
  • Distraction techniques, audio-visual entertainment, and relaxation methods are highly effective in reducing anxiety and improving cooperation in children 3

Special Considerations

  • Antihistamines are likely to cause sedation (66% vs. 44% with placebo), which may be beneficial for long journeys but problematic when alertness is required 5
  • Second-generation antihistamines (cetirizine, desloratadine, fexofenadine, levocetirizine, and loratadine) have been shown to be well-tolerated with a good safety profile in young children, though their efficacy for motion sickness is limited 3
  • For severe cases where pharmacological intervention is necessary in children over 6 years, meclizine at 12.5-25 mg can be considered 6, 7

Prevention Strategies

  • Position the child in the most stable part of the vehicle (middle seat, front seat for cars if age-appropriate) 8
  • Encourage the child to watch the true visual horizon when possible 8
  • Minimize exposure to other sources of physical, mental, and emotional discomfort during travel 8
  • Slow, intermittent exposure to motion can help reduce symptoms through habituation 8, 9

Common Pitfalls to Avoid

  • Long-term use of vestibular suppressant medications can interfere with natural adaptation to motion and should be avoided 6
  • Medications primarily treat symptoms rather than addressing the underlying sensory conflict 6
  • Combining multiple motion sickness medications can lead to overdose errors and increased risk of adverse effects 3
  • Medications should be administered before travel begins rather than after symptoms develop for maximum effectiveness 10

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Natural Methods for Managing Motion Sickness

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Antihistamines for motion sickness.

The Cochrane database of systematic reviews, 2022

Guideline

Motion Sickness Treatment Options

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Tratamiento para Cinetosis Severa

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Prevention and treatment of motion sickness.

American family physician, 2014

Research

Motion sickness: current concepts and management.

Current opinion in neurology, 2022

Research

Motion sickness: an overview.

Drugs in context, 2019

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.